Fig. 1
From: KCC2 expression levels are reduced in post mortem brain tissue of Rett syndrome patients
KCC2 immunohistochemistry in RTT patient brain. Representative image of immunofluorescent staining for KCC2 and MeCP2 in BA 20 of control (a) and RTT patient (b) tissue. Because of mosaic expression, MeCP2-positive cells are also detected in RTT patient tissue marked by arrowheads (b). Fluorescent intensity measurements indicated reduced KCC2 levels in RTT patient (Mann Whitney Test, ns.) (c)